✨ Your Portfolio is fetched and updated from zerodha.
Nano Diagnostic Chains

Nephro Care India Ltd.

NEPHROCARE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹124 Cr.
P/E
34.05

Nephro Care India Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
124 Cr
PE
PE
34.05
Prom Holding
Prom Holding
61.47 %
ROE (%)
ROE (%)
6.80
ROCE (%)
ROCE (%)
9.10
Div Yield (%)
Div Yield (%)
-
Sales
Sales
22.66 Cr
OPM (%)
OPM (%)
8.46 %
Debt to Equity
Debt to Equity
-
View more
Edit Ratio's

About

Nephro Care India specializes in treating kidney diseases with a team of experienced nephrolog… Read more
Low
70
52W Range
High
183
  • Nephro Care India
  • Modern Diagnostic
  • Invicta Diagnostic

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

6 Yes

Positive for this company

3 Neutral

Neutral for this company

6 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Peer Comparison

FAQs on Nephro Care India Ltd. Business

Nephro Care India is a healthcare provider that specializes in the treatment of kidney-related diseases. Its team of experienced nephrologists and healthcare professionals are dedicated to providing its patients with the highest quality care and treatment. The company also offers holistic treatment plans tailored to meet the unique needs of each patient.

Nephro Care India major competitors are Modern Diagnostic, Invicta Diagnostic, Aspira Pathlab&Diagn, Chandan Healthcare, Krsnaa Diagnostics, Vimta Labs, Thyrocare Tech..
Market Cap of Nephro Care India is ₹131 Crs.
While the median market cap of its peers are ₹670 Crs.

Nephro Care India seems to be less financially stable compared to its competitors.
Altman Z score of Nephro Care India is 7.08 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Nephro Care India Ltd.
The "Coiled Spring" Effect: Why Nephro Care India (NCIL) Is Poised for a Valuation Re-Rating - Dhruva Pandey
Interaction with the Management of Nephro Care India - Corporate Capital Ventures
Face to Face Corporate Series with the Management of Nephro Care India Limited - Avinash Gorakshakar
[]
Hospitals
The Business Model of Indian Hospitals Simplified - Anish Moonka
Effect Of Lease Accounting Changes & Why Debt To Equity Is Rising - SOIC
Hospital Sector - The Economics of CapEx - Abhay Sahukar
Case Mix Of Hospitals - Harshit Toshniwal
Hospital Sector Deep Dive! Part 2 - Who pays our bills? Payor mix, Profitability of payor types - Harshit Toshniwal
Hospital Sector Deep Dive! Part 3 - Unit Economics, IRR of Hospital bus., Doctor Engagement Models - Harshit Toshniwal
Hospital Sector Deep Dive! Part 7 - Stock preference in India Hospital Space - Harshit Toshniwal
Medical Costs - India vs Abroad - Trade Brains
Inside India’s Healthcare Stack: Capex-Heavy Hospitals, Supply Gaps & Venture-Scale Hospital Alts - Asymmetric
A thread on the Medical Tourism in India - Aditya Kondawar
How The Diagnostics Industry Works - PPFAS
Diagnostic Industry - P2P Analysis - SOIC
Impact on compeitition like TATA1MG on Diagnostics Sector - Aditya Khemka(Incred) - Bloomberg Quint
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material